[go: up one dir, main page]

PL3302463T3 - Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu - Google Patents

Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu

Info

Publication number
PL3302463T3
PL3302463T3 PL16733153T PL16733153T PL3302463T3 PL 3302463 T3 PL3302463 T3 PL 3302463T3 PL 16733153 T PL16733153 T PL 16733153T PL 16733153 T PL16733153 T PL 16733153T PL 3302463 T3 PL3302463 T3 PL 3302463T3
Authority
PL
Poland
Prior art keywords
deoxyanthyanidins
treatment
eye diseases
diseases
eye
Prior art date
Application number
PL16733153T
Other languages
English (en)
Inventor
Valérie FONTAINE
René LAFONT
José-Alain Sahel
Stanislas Veillet
Original Assignee
Biophytis
Sorbonne Universite
Centre National De La Recherche Scientifique (Cnrs)
INSERM (Institut National de la Santé et de la Recherche Médicale)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophytis, Sorbonne Universite, Centre National De La Recherche Scientifique (Cnrs), INSERM (Institut National de la Santé et de la Recherche Médicale) filed Critical Biophytis
Publication of PL3302463T3 publication Critical patent/PL3302463T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
PL16733153T 2015-05-27 2016-05-27 Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu PL3302463T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1554761A FR3036620B1 (fr) 2015-05-27 2015-05-27 Utilisation de 3-desoxyanthocyanidines pour le traitement de maladies oculaires
PCT/FR2016/051262 WO2016189260A1 (fr) 2015-05-27 2016-05-27 Utilisation de 3-désoxyanthocyanidines pour le traitement de maladies oculaires
EP16733153.7A EP3302463B1 (fr) 2015-05-27 2016-05-27 Utilisation de 3-désoxyanthocyanidines pour le traitement de maladies oculaires

Publications (1)

Publication Number Publication Date
PL3302463T3 true PL3302463T3 (pl) 2020-10-19

Family

ID=53524889

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16733153T PL3302463T3 (pl) 2015-05-27 2016-05-27 Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu

Country Status (11)

Country Link
US (1) US10513503B2 (pl)
EP (1) EP3302463B1 (pl)
JP (1) JP6738412B2 (pl)
KR (1) KR20180029978A (pl)
CN (1) CN107949382B (pl)
BR (1) BR112017025270B1 (pl)
ES (1) ES2796356T3 (pl)
FR (1) FR3036620B1 (pl)
PL (1) PL3302463T3 (pl)
RU (1) RU2730854C2 (pl)
WO (1) WO2016189260A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7537074B2 (ja) * 2016-05-10 2024-08-21 ソルボンヌ ウニベルシテ Cd47を活性化する作用物質およびその炎症治療における使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105675A (en) * 1976-03-01 1978-08-08 The Coca-Cola Company Method for making 3-deoxyanthocyanidins
FR2855172A1 (fr) * 2003-05-21 2004-11-26 Synth E 163 Composes 3-desoxyanthocyanidines et leurs utilisations comme agents antimicrobiens
WO2005077176A1 (en) 2004-02-11 2005-08-25 The Trustees Of Columbia University In The City Of New York Anthocyanin compounds and methods of use thereof
FR2973249B1 (fr) * 2011-03-28 2014-02-07 Centre Nat Rech Scient Utilisation de l'epigallocatechine gallate comme agent antiviral contre les infections par le virus de l'hepatite c
FR2975008B1 (fr) * 2011-05-13 2014-03-07 Inst Biophytis Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla)
CN104116876A (zh) * 2013-04-26 2014-10-29 株式会社海玛特 血管新生抑制剂、化妆品、药品、结晶化红色素、组合物、食品及其制造方法
JP6364362B2 (ja) * 2015-02-17 2018-07-25 学校法人福岡大学 ヒトキマーゼ阻害剤および機能性食品、並びにヒトキマーゼの活性を阻害する方法

Also Published As

Publication number Publication date
RU2017145659A (ru) 2019-06-27
ES2796356T3 (es) 2020-11-26
JP6738412B2 (ja) 2020-08-12
BR112017025270B1 (pt) 2024-01-09
EP3302463B1 (fr) 2020-03-25
JP2018515626A (ja) 2018-06-14
WO2016189260A1 (fr) 2016-12-01
RU2730854C2 (ru) 2020-08-26
US10513503B2 (en) 2019-12-24
US20180230119A1 (en) 2018-08-16
FR3036620B1 (fr) 2017-09-01
FR3036620A1 (fr) 2016-12-02
RU2017145659A3 (pl) 2019-09-11
EP3302463A1 (fr) 2018-04-11
BR112017025270A2 (pt) 2018-08-07
CN107949382A (zh) 2018-04-20
CN107949382B (zh) 2021-06-01
KR20180029978A (ko) 2018-03-21

Similar Documents

Publication Publication Date Title
IL283086A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
IL281793A (en) Use of cannabinoids in the treatment of epilepsy
IL279752B (en) Polycyclic compounds and use thereof in the treatment of immune disorders
MA45192A (fr) Traitement d'association
PL3157512T3 (pl) Zastosowanie kannabidioli w leczeniu padaczki
HUE061761T2 (hu) Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében
HRP20190117T1 (hr) iRNK TERAPIJA ZA LIJEČENJE BOLESTI OKA
GB201517215D0 (en) Use of cannabinoids in the treatment of inflammatory skin diseases
EP3359171C0 (en) Use of akkermansia muciniphila for treating inflammatory conditions
GB201614522D0 (en) Use of cannabinoids in the treatment of multiple myeloma
IL251530B (en) Use of cannabinoids in the treatment of degenerative skeletal muscle diseases
PT3481846T (pt) 24-hidroxiesteroides 11-substituídos para utilização no tratamento de afeções relacionadas com nmda
PL3503890T3 (pl) Stosowanie pridopidyny w leczeniu dystonii
HUE054783T2 (hu) Pridopidin Huntington-kór kezelésében
IL260684B (en) Treatment for modulating gut microbiota
EP3448263A4 (en) Electrotherapeutic treatment
HUE059387T2 (hu) Parkinson-kór kezelése
PL3732294T3 (pl) Tymohydrochinon do stosowania w leczeniu hiperglikemii
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
HUE062784T2 (hu) Indolinon vegyületek és alkalmazásuk fibrotikus betegségek kezelésében
IL264407A (en) Novel application of gzd824 and pharmaceutically acceptable salts thereof in treating diseases
HRP20180071T1 (hr) Upotreba kladribina u liječenju očnog neuromijelitisa
HUE056798T2 (hu) Imatinib stroke kezelésében való alkalmazásra
PL3373922T3 (pl) Kompozycje i sposoby do stosowania do leczenia homocystynurii
IL246855A0 (en) Materials for use in the treatment of retinitis